Lifshitz & Miller LLP Announces Investigation of Acacia Communications, Inc., AngioDynamics, Inc., ClubCorp Holdings, Inc., HD Supply Holdings, Inc., Ocular Therapeutix, Inc., Repros Therapeutics Inc. and Tahoe Resources Inc.

NEW YORK, July 24, 2017 /PRNewswire/ --

Acacia Communications, Inc. (ACIA)

Lifshitz & Miller announces investigation on behalf of ACIA investors concerning whether ACIA issued misleading statements about a purported quality issue impacting modules manufactured by one of ACIA's three contract manufacturers.

If you are an ACIA investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

AngioDynamics, Inc. (ANGO)

Lifshitz & Miller announces investigation on behalf of ANGO investors after ANGO disclosed in an SEC filing that its former independent auditor identified material weaknesses in ANGO's internal controls over financial reporting concerning cash flow projections and significant valuation model assumptions used in the goodwill impairment test.

If you are an ANGO investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

ClubCorp Holdings, Inc. (MYCC)

Lifshitz & Miller announces investigation into possible breaches of fiduciary duties by the board in connection with the proposed sale of MYCC to Apollo Global Management for $17.12 in cash for each share of MYCC owned.

If you are an MYCC investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

HD Supply Holdings, Inc. (HDS)

Lifshitz & Miller announces investigation on behalf of HDS investors concerning whether HDS issued misleading statements about the feasibility of its operating and growth leverage guidance and that HDS was exploring a sale of its Waterworks segment, a main business segment.

If you are an HDS investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

Ocular Therapeutix, Inc. (OCUL)

Lifshitz & Miller announces investigation on behalf of OCUL investors concerning whether OCUL's management issued misleading statements about its lead product, DEXTENZA, and failed to disclose manufacturing issues that could prevent FDA approval.

If you are an OCUL investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

Repros Therapeutics Inc. (RPRX)

Lifshitz & Miller announces investigation on behalf of RPRX investors concerning whether RPRX issued misleading statements about its development of Proellex after RPRX disclosed Proellex would remain on partial clinical hold based upon FDA review.

If you are an RPRX investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

Tahoe Resources Inc. (TAHO)

Lifshitz & Miller announces investigation on behalf of TAHO investors concerning whether TAHO issued misleading statements about consultation obligations relating to the permitting of the Escobal mining license.

If you are a TAHO investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

ATTORNEY ADVERTISING. © 2017 Lifshitz & Miller LLP.  The law firm responsible for this advertisement is Lifshitz & Miller LLP, 821 Franklin Avenue, Suite 209, Garden City, New York 11530, Tel: (516)493-9780.  Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact:

Joshua M. Lifshitz, Esq.
Lifshitz & Miller LLP
Phone:  516-493-9780
Facsimile: 516-280-7376
Email: [email protected]

SOURCE Lifshitz & Miller Law Firm

Related Links

http://jlclasslaw.com